These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 8296255)
1. Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients. Booth H; Fishwick K; Harkawat R; Devereux G; Hendrick DJ; Walters EH Thorax; 1993 Nov; 48(11):1121-4. PubMed ID: 8296255 [TBL] [Abstract][Full Text] [Related]
2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ; Winter TH; Aalbers R Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [TBL] [Abstract][Full Text] [Related]
3. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259 [TBL] [Abstract][Full Text] [Related]
4. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. Lipworth BJ; Aziz I J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190 [TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Kalra S; Swystun VA; Bhagat R; Cockcroft DW Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376 [TBL] [Abstract][Full Text] [Related]
6. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. Verberne AA; Hop WC; Bos AB; Kerrebijn KF J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):127-34. PubMed ID: 8093705 [TBL] [Abstract][Full Text] [Related]
8. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. Yates DH; Kharitonov SA; Barnes PJ Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342 [TBL] [Abstract][Full Text] [Related]
9. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction. Boulet LP; Turcotte H; Cartier A; Milot J; Côté J; Malo JL; Laviolette M Chest; 1998 Aug; 114(2):373-9. PubMed ID: 9726717 [TBL] [Abstract][Full Text] [Related]
10. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. Verberne AA; Hop WC; Creyghton FB; van Rooij RW; van den Berg M; de Jongste JC; Kerrebijn KF J Allergy Clin Immunol; 1996 Apr; 97(4):938-46. PubMed ID: 8655889 [TBL] [Abstract][Full Text] [Related]
11. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550 [TBL] [Abstract][Full Text] [Related]
12. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics. Wong AG; O'Shaughnessy AD; Walker CM; Sears MR Eur Respir J; 1997 Feb; 10(2):330-6. PubMed ID: 9042628 [TBL] [Abstract][Full Text] [Related]
13. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids. Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961 [TBL] [Abstract][Full Text] [Related]
14. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol. Aziz I; Lipworth BJ J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815 [TBL] [Abstract][Full Text] [Related]
15. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003 [TBL] [Abstract][Full Text] [Related]
16. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230 [TBL] [Abstract][Full Text] [Related]
17. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism. Lipworth BJ; Dempsey OJ; Aziz I Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119 [TBL] [Abstract][Full Text] [Related]
18. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction. Beach JR; Young CL; Stenton SC; Avery AJ; Walters EH; Hendrick DJ Pulm Pharmacol; 1992 Jun; 5(2):133-5. PubMed ID: 1611231 [TBL] [Abstract][Full Text] [Related]
20. An overview of nine clinical trials of salmeterol in an asthmatic population. Verberne AA; Fuller R Respir Med; 1998 May; 92(5):777-82. PubMed ID: 9713640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]